Ferroxidase II activity and serum cholesterol.
Ferroxidase II (Fox II) was developed in serum by acid incubation for 24 h. The resulting activity showed a strong positive correlation with the serum cholesterol concentration in normal subjects and patients with hyperlipidaemia. The potentiating effect of cholesterol on developed Fox II has been confirmed by the in-vitro addition of cholesterol to serum. There was no significant correlation between developed Fox II and caeruloplasmin (ferroxidase I) or between cholesterol and caeruloplasmin.
D002570:Ceruloplasmin / Q000097:blood; D002784:Cholesterol / Q000097:blood*; D006801:Humans; D006949:Hyperlipidemias / Q000097:blood*; D010088:Oxidoreductases / Q000378:metabolism*; D014280:Triglycerides / Q000097:blood
D014280:Triglycerides; D002784:Cholesterol; D010088:Oxidoreductases; C023100:ferroxidase II; D002570:Ceruloplasmin